Breaking News on Global Pharmaceutical Technology & Manufacturing

Colorcon and Dow extend controlled release alliance

22-Sep-2016 - Colorcon and Dow have expanded a nine year controlled release alliance to include further solubility, coating and ion exchange platforms.

Court rules in favour of Zydus' copy of Shire's controlled-release UC drug

19-Sep-2016 - Shire says it will appeal a decision invalidating a patent surrounding the controlled-release composition of its ulcerative colitis drug Lialda (mesalazine).

Lonza licenses rights to sell synthetic AAVs to gene therapy developers

14-Sep-2016 - Lonza has licensed rights to synthetic adeno-associated viral (AAV) vectors developed by scientists at US hearing research centre, Massachusetts Eye and Ear.

Bespak to supply AstraZeneca components for LAMA/LABA inhaler

14-Sep-2016 - AstraZeneca has struck a supply deal with Bespak for components in pressurised metered-dose inhalers (pMDIs) for a recently approved COPD treatment. 

Aptar and BD join forces on auto-injector device

14-Sep-2016 - Aptar Pharma has formed an alliance with Becton, Dickinson & Co to develop new self-injection devices that will tap into the strong growth in injectable drugs.

Novo Nordisk recalls GlucaGen HypoKit in US after error at syringe supplier

13-Sep-2016 - Novo Nordisk has recalled six lots of its GlucaGen HypoKit pen in the US after customers in Europe complained of detached needles.

Catalent to plug bioavailability tech gap with Pharmatek Laboratories buy

13-Sep-2016 - Catalent has announced its intention to buy Pharmatek Laboratories to boost its drug bioavailability offering.

Spain's Idifarma bolstered by investment from API maker Suanfarma

12-Sep-2016 - Spanish API maker Suanfarma has acquired a stake in contract manufacturer and spray-drying specialist Idifarma, boosting its international presence.

Gerresheimer to sell off non-core lab glass unit as part of delivery device focus

12-Sep-2016 - Gerresheimer has agreed to sell its lab glassware business to a private equity investor, describing the deal as part of an effort to focus on delivery devices and pharmaceutical packaging.

Allergan bolts on optogenetics platform with RetroSense buy

07-Sep-2016 - Allergan has added to its fast-growing eye health portfolio by buying gene therapy firm RetroSense Therapeutics for $60m (€53m) upfront.

When it comes to vaccine adjuvants, not all alum is equal

05-Sep-2016 - Aluminium adjuvants should not be used in trial placebos according to UK scientists who say the differing physical and biological properties of alum salt forms makes some safer than others.

Needle-free tech company partners with WHO as part of polio eradication effort

01-Sep-2016 - PharmaJet has inked a multi-year deal with the World Health Organization for its needle-free technology, which uses 80% less vaccine than traditional methods.  

Recipharm inks manufacturing and controlled release tech deal with Tillotts

01-Sep-2016 - Recipharma will provide pellet coating technology for controlled release drugs to Tillotts Pharma as part of a long-term manufacturing deal.

Flexible molecules could be better drugs - for some targets

31-Aug-2016 - For drug molecules, having a flexible rather than a rigid structure can sometimes make you a better medicine, say scientists in California.

RenovaCare looks to use skin as ‘natural bioreactor’ to treat burns

30-Aug-2016 - A device that isolates and sprays a patient’s own stem cells onto serious burns could have significant implications in the organ regeneration industry, says developer RenovaCare.

Catalent Q4 results

Catalent to add two 2,000L bioreactors in $34m WI biologics plant expansion

30-Aug-2016 - Catalent has more than doubled its biologics business since it went public in 2014, but the sector still represents less than 5% of the CDMO’s revenues.

Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse

25-Aug-2016 - Grunenthal has reiterated the benefits of its anti-crush intac tech after licensee Endo withdrew its request to have Opana ER labelled as “abuse deterrent."

Public Patheon's $2bn warchest may bolster biologics offering, analyst

17-Aug-2016 - Biomanufacturing demand will drive revenues for Patheon according to an Evercore ISI analyst, who has predicted the newly-listed CDMO will strengthen its capabilities through M&A.


US FDA changes policy on switching hard gel capsule suppliers

16-Aug-2016 - Drug manufacturers that change hard gelatin capsule suppliers do not need to seek approval beforehand under a policy introduced by the US FDA this week.

Antibiotic resistance most imminent threat to humanity, says bacteriophage maker

16-Aug-2016 - Phages, peptides and live biotherapeutics could help combat antibiotic-resistant bacteria but don’t expect heavy R&D investment until people start dying from post-operative infection, says EpiBiome.

Alnylam picks Jacobs to help construct $200m RNAi manufacturing plant in MA

08-Aug-2016 - Alnylam’s RNAi manufacturing plant will be operational by 2018 and the firm says it is willing to invest in a second facility depending on its pipeline success.

Acino agrees to sell drug delivery patch business to Luye Pharma for $274m

02-Aug-2016 - Acino has agreed to sell its transdermal delivery patch business Luye Pharma Group in a deal that will include its manufacturing site in Miesbach, Germany.

West: Amgen mAb approval helps validate drug delivery tech

01-Aug-2016 - Regulatory approvals are driving interest in West's Smartdose and Crystal Zenith delivery technologies, the firm says ahead of the launch of a monthly-dose version of Amgen's Repatha.

UK regulators OK two Oxford Biomedica sites for cell therapy processing

01-Aug-2016 - The MHRA has granted Oxford Biomedica permission to develop and manufacture cell therapies at two more sites in the UK.

Roche getting under the skin of biosimilar competition

25-Jul-2016 - Subcutaneous versions of its biologic blockbusters - including Mabthera and Herceptin - will help protect against biosimilar competition, says Roche.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...